| Literature DB >> 34635937 |
Kyoko Yamashita1,2, Yuki Funauchi3,4, Keiko Hayakawa3, Keisuke Ae3, Seiichi Matsumoto3, Kunihiro Ikuta5, Yoshihiro Nishida5,6, Teruko Ueno7, Yoshie Shimoyama8, Nobuyuki Hiruta9,10, Rikuo Machinami9,11, Hiroshi Kawachi12,9, Kengo Takeuchi12,9.
Abstract
Epithelioid malignant peripheral nerve sheath tumor (MPNST) is a rare subtype of MPNST composed of epithelioid cells with abundant cytoplasm. Currently, strong and diffuse immunostaining for S100 protein and SOX10 is generally regarded as a characteristic feature of epithelioid MPNST. However, malignant tumors with epithelioid morphology that arise from a peripheral nerve or a pre-existing benign nerve sheath tumor should be regarded as epithelioid MPNSTs when they do not show characteristic features that definitively lead to other specific diagnoses. Here, we describe 3 cases of epithelioid MPNST in the peripheral nerve or schwannoma that was negative for S100 protein and SOX10 expression. Instead, these tumors were positive for EMA, GLUT1, claudin 1, and cytokeratin to varying degrees, while all of them retained SMARCB1 and H3K27me3 by immunohistochemistry. EMA, GLUT1, and claudin 1 are known markers of perineurial cell differentiation; thus, they could possibly represent epithelioid MPNST with perineurial cell differentiation.Entities:
Keywords: Epithelioid MPNST; Epithelioid malignant peripheral nerve sheath tumor; Malignant schwannoma; Perineurial cell differentiation
Mesh:
Substances:
Year: 2021 PMID: 34635937 DOI: 10.1007/s00428-021-03218-y
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064